Investing.com - Molecular Templates (NASDAQ: MTEM) reported third quarter EPS of $-0.820, $0.62 worse than the analyst estimate of $-0.200. Revenue for the quarter came in at $6.8M versus the consensus estimate of $2.32M.
Molecular Templates's stock price closed at $5.610. It is down -38.620% in the last 3 months and up 835.000% in the last 12 months.
Molecular Templates saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Molecular Templates's stock price’s past reactions to earnings here.
According to InvestingPro, Molecular Templates's Financial Health score is "fair performance".
Check out Molecular Templates's recent earnings performance, and Molecular Templates's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar